Abstract
MANY N-nitroso compounds are toxic, carcinogenic, mutagenic and teratogenic, and several are known to give rise to alkylating intermediates in the body1. The nitrosamines (for example, dimethylnitrosamine) require activation by enzymes before yielding these intermediates but nitrosamides (for example, N-methylnitrosourea) may react with nucleic acids and proteins without metabolic activation. The nature of the various intermediates between the nitroso compound and the intracellular methylating agent has not been established, however, and the question of the duration of their existence in the body arises. With dimethylnitrosamine, the acute lesion is mainly severe necrosis of the centrilobular zones of the liver, including damage to the hepatic sinusoids and central veins as well as to the centrilobular parenchymal cells2,3. It therefore follows that at least one of the intermediates must be of sufficient stability to damage the vascular cells. Since dimethylnitrosamine is active in the host-mediated assay for mutagenesis4 an active intermediate must also be capable of passing into the peritoneal cavity. N-methylnitrosourea is mutagenic in bacteria5 and is known to induce chromosomal aberrations in mammalian and plant cells in vitro6,7.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Magee, P. N., Montesano, R., and Preussmann, R., in Chemical Carcinogens (edit. by Searle, C. E.) (Am. chem. Soc., New York, in the press).
McLean, E., Bras, G., and McLean, A. E. M., Br. J. exp. Path., 46, 367–369 (1965).
Butler, W. H., and Hard, G. C., Expl molec. Path., 15, 209–219 (1971).
Gabridge, M. G., and Legator, M. S., Proc. Soc. exp. Biol. Med., 130, 831–834 (1969).
Neale, S., Mutat. Res., 14, 155–164 (1972).
Michaelis, A., Schoneich, J., and Rieger, R., Chromosoma, 16, 101–123 (1965).
Kucera, J., Chromosoma, 39, 45–51 (1972).
Miller, J. A., Cancer Res., 30, 559–576 (1970).
Magee, P. N., in Essays in Biochemistry, 10, (edit. by Campbell, P. N., and Dickens, F.), 105–136 (C. R. C., Cleveland, Ohio, 1974).
Latt, S. A., Proc. natn. Acad. Sci. U.S.A., 71, 3162–3166 (1974).
Yoder, J., Watson, M., Benson, W. W., Mutat. Res., 21, 335–340 (1973).
Lilly, L. J., Toxicology, 4, 331–340 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
LILLY, L., BAHNER, B. & MAGEE, P. Chromosome aberrations induced in rat lymphocytes by N-nitroso compounds as a possible basis for carcinogen screening. Nature 258, 611–612 (1975). https://doi.org/10.1038/258611a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/258611a0
This article is cited by
-
Artificial intelligence uncovers carcinogenic human metabolites
Nature Chemical Biology (2022)
-
Analyses for in vitro growth conditions, cytokinetics, and sister chromatid exchanges in lymphocytes cultured from the Sprague-Dawley rat
In Vitro Cellular amp; Developmental Biology (1985)
-
Tumor frequency and characteristics after a single dose of dimethylnitrosamine or diethylnitrosamine in partially hepatectomized rats
Zeitschrift f�r Krebsforschung und Klinische Onkologie (1977)
-
Short term screening tests for carcinogens
Nature (1976)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.